Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study | April 2022

Articles

NCBI>Innovations in Clinical Neuroscience

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341320/

The Effectiveness of Lurasidone Add-On for Residual Aggressive Behavior and Obsessive Symptoms in Antipsychotic-Treated Children and Adolescents with Tourette Syndrome: Preliminary Evidence from a Case Series | February 2021

Articles

Children

https://www.mdpi.com/2227-9067/8/2/121

Clinical and Cost Consequences of Metabolic Effects of Lurasidone versus Other Atypical Antipsychotics in Schizophrenia | June 2014

Articles

Open Medicine Journal

https://benthamopen.com/ABSTRACT/MEDJ-1-1

Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression | September 2021

Articles

Journal of Child and Adolescent Psychopharmacology

https://www.liebertpub.com/doi/10.1089/cap.2021.0040

Efficacy of Lurasidone in Major Depression with Mixed Features: Pattern of Improvement in Depressive and Manic Symptoms (Meetings-Events) | March 2016

Abstracts

European Psychiatry

https://www.sciencedirect.com/science/article/abs/pii/S0924933816015297

Lurasidone as Adjunctive Therapy with Lithium or Valproate for the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study | February 2014

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.13070985

Lurasidone Effects on Cognition and Functional Capacity in Schizophrenia | May 2016

Articles

Clinical Neuropsychopharmacology and Therapeutics

http://doi.org/10.5234/cnpt.7.11

Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR | July 2020

Articles

Clinical Drug Investigation

https://link.springer.com/article/10.1007/s40261-020-00944-0

Lurasidone in the Treatment of Schizophrenia: Results of a Double-Blind, Placebo-Controlled Trial in Asian Patients | April 2019

Abstracts

Asia-Pacific Psychiatry

https://onlinelibrary.wiley.com/doi/10.1111/appy.12352

Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study | August 2017

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568017/

Optimizing Treatment with Lurasidone in Patients with Schizophrenia: Results of a Randomized, Double-Blind, Placebo-Controlled Trial (Meetings-Events) | October 2015

Abstracts

European Psychiatry

https://www.sciencedirect.com/science/article/abs/pii/S0924933815320964

Identification of Clinical Phenotypes in Schizophrenia: The Role of Lurasidone | May 2021

Articles

Therapeutic Advances in Psychopharmacology

https://journals.sagepub.com/doi/10.1177/20451253211012250

Antipsychotic Treatments: Focus on Lurasidone | August 2013

Articles

Frontiers in Pharmacology

https://www.frontiersin.org/articles/10.3389/fphar.2013.00102/full

Lurasidone: A Novel Antipsychotic Agent for the Treatment of Schizophrenia and Bipolar Depression | October 2015

Articles

BJPsych Bulletin

https://doi.org/10.1192/pb.bp.114.048793

The Clinical Utility of Lurasidone in Schizophrenia: Patient Considerations | April 2015

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/the-clinical-utility-of-lurasidone-in-schizophrenia-patient-considerat-peer-reviewed-article-NDT

Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study | May 2021

Abstracts

CNS Spectrums

https://doi.org/10.1017/s1092852920002321

A 6-Week, Double-Blind, Placebo- and Haloperidol-Controlled, Phase II Study of Lurasidone in Patients with Acute Schizophrenia | October 2015

Articles

NCBI>Therapeutic Advances in Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722503/

Lurasidone in Therapy of Treatment-Resistant Ultra-Rapid Cycling Bipolar Disorder: Case Report | August 2021

Articles

Clinical Psychopharmacology and Neuroscience

https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2021.19.3.568

Health-Related Quality of Life among Patients Treated with Lurasidone: Results from a Switch Trial in Patients with Schizophrenia | February 2014

Articles

BMC Psychiatry

https://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-14-53

Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study | February 2014

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2013.13070984

Major Depressive Disorder with Mixed Features and Treatment Response to Lurasidone: A Symptom Network Model | August 2020

Articles

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/pii/S0165032720326549

Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial | December 2020

Articles

Journal of Child and Adolescent Psychopharmacology

https://www.liebertpub.com/doi/10.1089/cap.2020.0018

Lurasidone Favorably Affects Metabolic Syndrome Risk (Meetings-Events) | November 2014

Abstracts (Summaries)

MDedge>European College of Neuropsychopharmacology

https://www.mdedge.com/familypracticenews/article/88615/schizophrenia-other-psychotic-disorders/lurasidone-favorably

Double-Blind Comparison of the Safety and Efficacy of Lurasidone and Ziprasidone in Clinically Stable Outpatients with Schizophrenia or Schizoaffective Disorder | September 2011

Abstracts

Schizophrenia Research

https://www.sciencedirect.com/science/article/pii/S0920996411002143

Cost-Utility Analysis of Lurasidone versus Aripiprazole in Adults with Schizophrenia | April 2016

Articles

PharmacoEconomics

https://link.springer.com/article/10.1007/s40273-016-0405-0

Lurasidone for the Treatment of Depressive Symptoms in Schizophrenia: Analysis of 4 Pooled, 6-Week, Placebo-Controlled Studies | June 2014

Articles

CNS Spectrums

http://dx.doi.org/10.1017/S1092852914000285

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study | August 2021

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/safety-and-effectiveness-of-lurasidone-in-patients-with-schizophrenia--peer-reviewed-fulltext-article-NDT

The Direct and Indirect Effects of Lurasidone Monotherapy on Functional Improvement among Patients with Bipolar Depression: Results from a Randomized Placebo-Controlled Trial | March 2016

Articles

International Journal of Bipolar Disorders

http://journalbipolardisorders.springeropen.com/articles/10.1186/s40345-016-0049-1

Impact of Lurasidone on Health-Related Quality of Life in Adults with Bipolar Depression: A Post-Hoc Analysis | June 2022

Articles

Current Medical Research and Opinion

https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2083400

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study of Lurasidone for the Maintenance of Efficacy in Patients with Schizophrenia | December 2015

Articles

Journal of Psychopharmacology

http://jop.sagepub.com/content/30/1/69

Lurasidone Dose Response in Bipolar Depression: A Population Dose-Response Analysis | December 2015

Articles

Clinical Therapeutics

https://www.sciencedirect.com/science/article/pii/S0149291815012977

Effect of Lurasidone Dose on Cognition in Patients with Schizophrenia: Post-Hoc Analysis of a Long-Term, Double-Blind Continuation Study | June 2015

Articles

Schizophrenia Research

https://www.sciencedirect.com/science/article/pii/S0920996415003230

Weight Change During Long-Term Treatment with Lurasidone: Pooled Analysis of Studies in Patients with Schizophrenia | November 2015

Articles

International Clinical Psychopharmacology

http://dx.doi.org/10.1097/YIC.0000000000000091

Effect of Lurasidone on Manic Symptoms and Treatment-Emergent Mania in Adult and Pediatric Populations with Bipolar Depression | May 2021

Abstracts

CNS Spectrums

https://doi.org/10.1017/s1092852920002333

A Network Meta-Analysis of the Dose-Response Effects of Lurasidone on Acute Schizophrenia | March 2021

Articles

Scientific Reports

https://www.nature.com/articles/s41598-021-84836-z

Efficacy and Safety of Lurasidone in Adolescents and Young Adults with Schizophrenia: A Pooled Post Hoc Analysis of Double-Blind, Placebo-Controlled 6-Week Studies | May 2021

Articles

European Psychiatry

https://doi.org/10.1192/j.eurpsy.2021.30

Lurasidone for the Treatment of Bipolar Depression: An Evidence-Based Review | August 2015

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/lurasidone-for-the-treatment-of-bipolar-depression-an-evidence-based-r-peer-reviewed-article-NDT

Lurasidone in the Treatment of Acute Schizophrenia: A Double-Blind, Placebo-Controlled Trial | June 2009

Abstracts

NCBI>Journal of Clinical Psychiatry

https://www.ncbi.nlm.nih.gov/pubmed/19497249

Lurasidone as a Potential Therapy for Bipolar Disorder | October 2013

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/lurasidone-as-a-potential-therapy-for-bipolar-disorder-peer-reviewed-article-NDT

Lurasidone and Risk of Metabolic Syndrome: Results from Short and Long-Term Studies in Patients with Bipolar Depression | March 2022

Articles

CNS Spectrums

https://doi.org/10.1017/S1092852923001190

Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia | July 2021

Articles

International Journal of General Medicine

https://doi.org/10.2147/IJGM.S320611

Comparison of Lurasidone versus Quetiapine for the Treatment of Delirium in Critically Ill Patients | January 2018

Abstracts

Journal of Intensive Care Medicine

https://journals.sagepub.com/doi/10.1177/0885066617754187

Early Onset Tardive Syndromes Associated with Lurasidone in Patients with Mood Disorders: A Case Series and Literature Review | September 2022

Articles

Journal of Affective Disorders Reports

https://www.sciencedirect.com/science/article/pii/S2666915322001159

Lurasidone an Effective Alternative for the Treatment of Irritability Associated with Autism Spectrum Disorder | December 2020

Articles

Cureus

https://doi.org/10.7759/cureus.12360

Modulation of Anterior Cingulate Cortex Reward and Penalty Signalling in Medication-Naive Young-Adult Subjects with Depressive Symptoms Following Acute Dose Lurasidone | January 2019

Articles

Psychological Medicine

https://doi.org/10.1017/S0033291718003306

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis | September 2015

Articles

NCBI>Current Neuropharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761637/

Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy | September 2023

Articles

Drug Design, Development and Therapy

https://doi.org/10.2147/DDDT.S366769

Management of Bipolar I Depression: Clinical Utility of Lurasidone | January 2015

Articles

Therapeutics and Clinical Risk Management

https://www.dovepress.com/management-of-bipolar-i-depression-clinical-utility-of-lurasidone-peer-reviewed-article-TCRM

Pharmacokinetics and Tolerability of Lurasidone in Children and Adolescents with Psychiatric Disorders | November 2015

Articles

Clinical Therapeutics

https://www.sciencedirect.com/science/article/pii/S0149291815012163

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study | September 2011

Articles

American Journal of Psychiatry

https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2011.10060907